Effectiveness of zinc sulfate in common cold symptoms in children

Evaluation of the effectiveness of zinc sulfate in reducing duration of common cold symptoms in children

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT138903184056N2

Enrollment

112

Registered

2010-06-14

Start date

2007-04-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cold. Acute nasopharyngitis (common cold)

Interventions

Intervention 1: In case group , use of zinc sulfate (1mg/kg) once a day for 10 days. Intervention 2: Control group did not receive Zinc Sulfate.

Treatment - Drugs

In case group , use of zinc sulfate (1mg/kg) once a day for 10 days

Control group did not receive Zinc Sulfate

Eligibility

Sex/Gender

All

Age

1 Years to 7 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: children between 1 to 7 years old diagnosed by a pediatrician as having common cold based on symptoms; not receiving antibiotics. Exclusion criteria: parents not willing to participate in the study and antibiotic use.

Exclusion criteria

Exclusion criteria:

Design outcomes

Secondary

Measure	Time frame
Secondary bacterial infections. Timepoint: 15- 20 days after the end of treatment. Method of measurement: Pediatrician statement - Blood test results.;School absence. Timepoint: 15- 20 days after the end of treatment. Method of measurement: parental statement.;Excessive cost for treatment. Timepoint: 15- 20 days after the end of treatment. Method of measurement: parental statement.	—

Primary

Measure	Time frame
Nasal obstruction. Timepoint: 10 days after starting treatment - Daily for 10 days. Method of measurement: Asking mother and child via a questionnaire.;Runny nose. Timepoint: 10 days after starting treatment-Daily for 10 days. Method of measurement: Asking mother and child via a questionnaire.;Cough. Timepoint: 10 days after starting treatment - Daily for 10 days. Method of measurement: Asking mother and child via a questionnaire.;Sneezing. Timepoint: 10 days after starting treatment - Daily for 10 days. Method of measurement: Asking mother and child via a questionnaire.;Fever. Timepoint: 10 days after starting treatment. Method of measurement: Asking mother and child via a questionnaire -Thermometer.	—

Measure

Time frame

Nasal obstruction. Timepoint: 10 days after starting treatment - Daily for 10 days. Method of measurement: Asking mother and child via a questionnaire.;Runny nose. Timepoint: 10 days after starting treatment-Daily for 10 days. Method of measurement: Asking mother and child via a questionnaire.;Cough. Timepoint: 10 days after starting treatment - Daily for 10 days. Method of measurement: Asking mother and child via a questionnaire.;Sneezing. Timepoint: 10 days after starting treatment - Daily for 10 days. Method of measurement: Asking mother and child via a questionnaire.;Fever. Timepoint: 10 days after starting treatment. Method of measurement: Asking mother and child via a questionnaire -Thermometer.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Parsa Yousefi

AraK University of Medical Sciences

moghadasi@arakmu.ac.ir+98 86 1313 5075

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026